Wockhardt Limited (WOCKPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Wockhardt Limited (NSE: WOCKPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Pharma. As of 21 Sep 2026, the share price was ₹2,086.00, market capitalisation ₹33,897 Cr, P/E 85, ROE 6.11%.
Get the AI verdict on WOCKPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
WOCKPHARMA price and valuation
- Share price
- ₹2,086.00
- Market cap
- ₹33,897 Cr
- P/E ratio
- 85
- P/B ratio
- 6.86
- EPS
- ₹25.17
- Book value per share
- ₹304.00
- Dividend yield
- 0%
WOCKPHARMA profitability and growth
- ROE
- 6.11%
- ROCE
- 7.55%
- Debt to equity
- 0.42
- Revenue growth (3 yr)
- 8%
- Revenue growth (5 yr)
- 4%
- Profit growth (3 yr)
- 43%
- Profit growth (5 yr)
- -19%
WOCKPHARMA 52-week range
- 52-week high
- ₹2,422.30
- 52-week low
- ₹1,086.70
- Face value
- ₹5.00
WOCKPHARMA shareholding pattern
- Promoters
- 49.09%
- FIIs
- 7.23%
- DIIs
- 9.24%
- Public
- 34.44%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Pharma, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.